Literature DB >> 20549081

Late auditory event-related evoked potential (P300) in Down's syndrome patients.

Carla Patrícia Hernandez Alves Ribeiro César1, Heloisa Helena Caovilla, Mário Sérgio Lei Munhoz, Maurício Malavasi Ganança.   

Abstract

UNLABELLED: Down syndrome is caused by a trisomy of chromosome 21 and is associated with central auditory processing deficit, learning disability and, probably, early-onset Alzheimer's disease. AIM: To evaluate the latencies and amplitudes of evoked late auditory potential related to P300 events and their changes in young adults with Down's syndrome.
MATERIALS AND METHODS: Prospective case study. P300 test latency and amplitudes were evaluated in 17 individuals with Down's syndrome and 34 healthy individuals. RESULTS The P300 latency (N1, P2, N2 and P3) was longer and the N2-P3 amplitude was lower in individuals with Down syndrome when compared to those in the control group.
CONCLUSION: In young adults with Down syndrome, N1, P2, N2 and P3 latencies of late auditory evoked potential related to P300 events were prolonged, and N2 - P3 amplitudes were significantly reduced, suggesting integration impairment between the auditory association area and cortical and subcortical areas of the central nervous system.

Entities:  

Mesh:

Year:  2010        PMID: 20549081      PMCID: PMC9446017     

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


INTRODUCTION

Langdon Down described Down's syndrome, or the chromosome 21 trisomy, over a century ago; it is considered the most common genetic cause of mental retardation. The typical chromosomal changes in this syndrome comprise a homogeneous group that makes it easy to understand the findings. Diffuse injury or dysfunction in certain central areas, failure in habituation mechanisms, poor central inhibition of afferent stimuli, or cognition disorders may give rise to decreased brain electrical activity in Down's syndrome. The long latency event-related evoked potential (P300) is associated with cognition; it is generated when a random infrequent stimulus is detected among a series of frequent stimuli.7, 8, 9 The parameters assessed are latency and amplitude. Latency varies according to an individual's difficulty in discriminating a rare tones among frequent stimuli; amplitude varies according to the improbability of the stimulus. Waves N2 and P3 are the most important because they represent physiological phenomena associated with memory and learning mental events. Wave N2 is associated with decision-making or discrimination of stimuli; absent N2 and P3 waves suggest more severe involvement, such as pre-senile or senile dementia. Increased P3 latency and decreased P3 amplitude4, 5,,14, 15, 16, 17 have been identified in Down's syndrome. Increased latency appears to be associated with sensory and cognitive deficiencies in information processing, in particular by delaying the categorization of auditory information, and may be due to differences in the brain's ability to organize and respond in Down's syndrome. Increased P3 latency and decreased P3 amplitude, seen in healthy ageing individual,18, 19 have been found at an earlier age - about 20 years earlier, - in patients with Down's syndrome. A line of theory considers the possibility of an Alzheimer's type pre-senile dementia in subjects with Down's syndrome, underlining the importance of P300 to investigate the triad: ageing/Down's syndrome/Alzheimer's disease. The lack of Brazilian papers on the use of P300 in Down's syndrome motivated this study. The purpose of this study was to assess late event-related auditory evoked potentials (P300) in young adults with Down's syndrome.

MATERIALS AND METHODS

The Institutional Review Board of the institution in which the investigation was carried out approved this study (number 181/96). We undertook a prospective study comprising subjects aged from 18 to 39 years with a diagnosis of Down's syndrome. These patients were referred from a specialized institution on this condition; their parents or caretakers gave their free permission for each patient to participate. There were 17 subjects (10 male and seven female). Parents or caretakers of the subjects were informed of the study procedures and signed a free informed consent form for P300 to be done on the patients. The control group consisted of healthy subjects with no neurological or auditory complaints and no history of (or suspected history of) first degree family members with dementia. The control group comprised 34 subjects (20 male and 14 female) aged from 18 to 39 years. This group had twice the number of patients in the Down's syndrome group, to increase test reliability. Subjects in both groups were asked to refrain from stressful physical and mental activities before undergoing the auditory P300 testing. Those that did not follow this instruction or that slept during the procedure were excluded from the sample. The Nicolet Compact Auditory (Nicolet Biomedical Instruments) ran the P300 program with the following parameters: pure tone stimulus, frequent tone (EF) at 750 Hz, and rare tone (ER) at 2,000 Hz; binaural presentation mode; 70 dBHL intensity with 700 ms intervals between tones; and a 4/1 proportion for randomly presenting EF/ER (odd ball paradigm). Electrodes were placed on Cz (A1 and A2) and Pz (A1 and A2). TDH-39 earphones were used. About 300 stimuli were presented. Testing took place in an acoustically isolated and semi-darkened silent room; patients were comfortably seated on a reclining seat with head support. The skin and scalp were cleaned with an abrasive paste (OMNI), after which electrolytic gel was placed between the skin and electrodes to increase conductivity. Electrodes were fixed with microporeT plaster on the frontal (Fpz), vertical (Cz) and parietal (Pz) regions, and left ear (A1) and right ear (A2) lobules, according to the 10–20 international standard.21 The electrodes were connected to a preamplifier, in turn connected to the subject's clothes. Electrode polarity was positive in Cz and Pz, and negative in A1 and A2 (interlinked with a jumper). The electrical impedance was less than 5 KOhms in each derivation, and less than 3 KOhms between two different derivations throughout the procedure. Electroencephalogram waves were amplified 10,000 times; the bandwidth ranged from 1 to 30 Hz; the sensitivity was about 50mv. Artifacts were rejected by an internal circuit in the device that excluded all recordings with potentials over 45mv from the mediation process. Testing was interrupted if artifacts surpassed 20% of the presented stimuli, and the patient was asked to avoid muscle tension, and eye and body movements; after a 5-minute rest period, the test was restarted. Study subjects were asked to remain alert and relaxed for testing. They had to raise their hands or a flag gently only for rare tones to demonstrate tone discrimination and attentiveness. At the beginning of the test some of the subjects with Down's syndrome required new instructions, as they raised their hands or the flag and did not bring it down afterwards; the test was restarted only after it was fully understood. Each procedure lasted about thirty minutes: 15 minutes were required for preparing and placing the electrodes, data entry, and checking the impedance; 3 minutes were needed for the pre-test phase, during which the examiner identified rare tones with each subject until he or she could perform it alone; the test itself took from seven to 10 minutes. Waves N1, P2, N2 and P3 had, respectively, negative-positive-negative-positive polarities, and were recorded and replicated when frequent and rare tones were presented. N1 and P2 were marked on the frequent tones, and N1, N2 and P3 were marked on rare tones. Latency was measured at the maximum deflection point in each wave, and amplitude was measured between the maximum N1 and P2, and N2 and P3 deflection points. Peaks with the highest deflection or waves that were best duplicated were measured in double, triple or multiple peak waves. P300 component latency and amplitude values were tabulated for the control group and the Down syndrome group. The mean latencies and amplitudes in each group were compared and related with gender. The Mann-Whitney test, used for comparing independent samples, was applied for the statistical analysis. The significance level was 5%. Significant data were marked with an asterisk.

RESULTS

There were 51 subjects aged from 18 to 39 years; 30 were male and 21 were female. All were able to perform the test without difficulty. Table 1 shows N1, P2, N2 and P3 latency values and N1-P2 and N2-P3 amplitude values for 17 subjects with Down's syndrome. Table 2 shows N1, P2, N2 and P3 latency values and N1-P2 and N2-P3 amplitude values of 34 controls.
Table 1

Values of N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes in 17 subjects with Down's syndrome.

PatientAgeN1 LatencyP2 LatencyN2 LatencyP3 LatencyN1-P2 AmplitudeN2-P3 Amplitude
S119112,0198,4457,6540,814,26,0
S220102,4172,8272,0326,418,03,9
S321108,8179,2275,2329,64,16,2
S421102,4176,0236,8307,26,65,8
S523105,6153,6281,6374,45,84,3
S624112,0192,0240,0355,28,411,9
S72589,6153,6294,4364,88,45,3
S825112,0198,4272,0320,03,33,7
S925108,8150,4243,2361,65,83,5
S102586,4192,0307,2345,612,12,7
S112699,2179,2256,0313,610,19,0
S1227102,4176,0291,2342,410,72,9
S132799,2192,010,7
S1427105,6188,8272,0348,811,14,7
S1527108,8150,4252,8310,48,45,8
S1635115,2185,6259,2297,68,21,9
S1738105,6176,0396,8476,84,33,3
Mean25,6104,5177,3288,0357,28,95,1

KEY: Snumber = Subjectnumber

Table 2

Values of N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes in 34 healthy subjects in the control group.

PatientAgeN1 LatencyP2 LatencyN2 LatencyP3 LatencyN1-P2 AmplitudeN2-P3 Amplitude
S11886,4118,4144,0320,02,712,9
S21899,2163,2201,6243,29,01,4
S32192,8160,0195,2278,43,19,0
S422131,2156,8211,2291,23,516,4
S52289,6172,8233,6265,611,10,8
S622102,4192,0300,8352,09,87,2
S72396,0134,4182,4243,28,010,1
S82389,6166,4214,4300,86,814,8
S92396,0211,2272,0300,816,01,7
S1023108,8166,4217,6336,07,68,6
S112399,2172,8198,4300,89,73,7
S122492,8140,8179,2224,05,312,3
S132499,2144,0198,4345,67,09,8
S142496,0163,2201,6265,610,09,0
S152496,0115,2137,6262,41,416,0
S162596,0140,8185,6252,83,520,1
S1725102,4160,0188,8236,86,07,0
S182589,6153,6224,0284,810,114,8
S192696,0147,2195,2220,815,04,5
S202696,0176,0230,4291,211,55,7
S212699,2160,0204,8243,24,38,8
S222683,2156,8214,4304,010,010,9
S232696,0179,2233,6307,29,210,1
S2426102,4150,4195,2297,68,87,8
S252689,6115,2163,2272,02,310,9
S2627115,2160,0195,2304,07,820,9
S2727108,8163,2201,6291,26,43,1
S2827105,6150,4211,2300,88,010,5
S2929108,8140,8172,8236,84,110,1
S302999,2160,0217,6294,46,810,5
S3131115,2137,6166,4268,81,913,7
S323699,2204,8259,2307,211,56,4
S333699,2198,4297,6358,412,19,8
S343996,0150,4195,2307,210,00,6
Mean25,699,2158,3207,1285,67,79,4

KEY: Snumber = Subjectnumber

Values of N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes in 17 subjects with Down's syndrome. KEY: Snumber = Subjectnumber Values of N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes in 34 healthy subjects in the control group. KEY: Snumber = Subjectnumber Tables 3 and 4 show the influence of gender on N1, P2, N2 and P3 latency values and N1-P2 and N2-P3 amplitude values of 17 with Down's syndrome and of controls. The Mann-Whitney test, at a 5% significance level, revealed no statistically significant gender differences.
Table 3

Mean values of age, N1, P2, N2 and P3 latencies, and N1-P2 and N2-P3 amplitudes of 17 subjects with Down's syndrome according to gender.

ParametersGender Male Mean ValuesGender Female Mean Valuesp - value
Age26,823,90,2768
N1 latency103,0106,50,5540
P2 latency180,2173,30,3019
N2 latency303,6267,90,5593
P3 latency364,1348,30,3683
N1 - P2 amplitude8,69,10,9609
N2 - P3 amplitude4,95,30,7911

Mann-Whitney test

Table 4

Mean values of aged, N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes of 34 controls according to gender.

ParametersGender Male Mean ValuesGender Female Mean Valuesp - value
Age26,624,20,1207
N1 latency99,299,20,7899
P2 latency157,9158,90,9580
N2 latency201,9214,40,1456
P3 latency285,3285,90,8885
N1 - P2 amplitude7,08,60,1414
N2 - P3 amplitude9,88,90,6743

Mann-Whitney test

Mean values of age, N1, P2, N2 and P3 latencies, and N1-P2 and N2-P3 amplitudes of 17 subjects with Down's syndrome according to gender. Mann-Whitney test Mean values of aged, N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes of 34 controls according to gender. Mann-Whitney test Table 5 shows a comparison of N1, P2, N2 and P3 mean latencies between both groups. The Down's syndrome group showed a statistically significant increase in N1, P2, N2 and P3 latencies compared to controls.
Table 5

Comparison of mean N1, P2, N2 and P3 latencies of 17 subjects with Down's syndrome and 34 controls.

LatencyDown's syndrome Mean ValuesControl Group Mean Valuesp - value
N1104,599,20,0088*
P2177,3158,30,0032*
N2288,0207,00,0000*
P3357,2285,50,0000*

Mann-Whitney test

Comparison of mean N1, P2, N2 and P3 latencies of 17 subjects with Down's syndrome and 34 controls. Mann-Whitney test Table 6 shows a comparison of mean N1-P2 and N2-P3 amplitudes in 17 subjects with Down's syndrome and 34 controls. A statistically significant difference was found in N2-P3 amplitudes, which were lower in the Down's syndrome group compared to controls.
Table 6

Comparison of mean N1-P2 and N2-P3 amplitudes of 17 subjects with Down's syndrome and 34 controls.

AmplitudesDown's syndrome Mean ValuesControl Group Mean Valuesp - value
N1-P28,87,70,3224
N2-P35,09,40,0023*

Mann-Whitney test

Comparison of mean N1-P2 and N2-P3 amplitudes of 17 subjects with Down's syndrome and 34 controls. Mann-Whitney test

DISCUSSION

In this study, P300 was easy to apply and interpret in subjects with Down's syndrome. All study and control subjects avoided physical activities and stressful mental work before undertaking the auditory P300 test; we were careful to exclude from the sample the subjects that did not follow the instructions, or that were fatigued, inattentive, or that slept during the procedure. The parameters that were assessed were N1, P2, N2 and P3 latencies and N1-P2 and N2-P3 amplitudes. Of 17 subjects with Down's syndrome, 12 (70.6%) showed one or more abnormalities in N2 and P3 latencies and/or N1-P2 and N2-P3 amplitudes. We found delayed N2 latency in 29.4% of cases, delayed N2 and P3 latencies in 23.5%, delayed P3 latency in 5.9%, delayed N2 latency and increased N1-P2 amplitude in 5.9%, and absent N2 and P3 components in 5.9%, compared with the results of healthy subjects using the same procedure of raising one's hand upon hearing a rare tone. We found that N1, P2, N2 and P3 latencies were higher in the Down's syndrome group, which concurred with other studies.5, 6, The difference of the mean P3 latency between subjects with Down's syndrome and controls was 71 ms, suggesting that the estimated mean age of Down's syndrome subjects would be 96 years, which contrasts with their mean reported chronological age (25 years). The literature we reviewed suggested that the P300 test would demonstrate the effects of human ageing, observed in a slowing of the stimulus assessment process and decreased selective attention ability; P3 latency increases by about one millisecond a year throughout life. As the P3 latency is elevated in healthy elderly subjects and in Down's syndrome subjects,, we assumed that the early ageing hypothesis that is reported in the literature could be applied to our study group. However, the elevation in P3 latency we found might also be related only with sensory and cognitive information processing deficiencies, which would delay categorization of auditory information, and which may have been attributed to differences in the ability of the brain of Down's syndrome subjects to organize information and respond. N1-P2 amplitudes were similar in subjects with Down's syndrome and controls, while N2-P3 amplitude was lower in the Down's syndrome group. These results concur with other findings in the literature.16, 17 As amplitude decreases with ageing in healthy subjects,18, 19 our findings in some subjects with Down's syndrome led us to hypothesize the possibility of early ageing, compared to controls, and point to the neurological and cognitive losses in our study sample. Decreased N2-P3 amplitude might suggest that few fibers are conducting the stimuli, indicating that there might be loss of auditory attentiveness and poor cognition. Altered P300 latencies and amplitudes may be justified in different theoretical perspectives; there might be failure in cortical habituatioin,4, 5, 6 a decreased number of nervous fibers for conducting auditory stimuli, the cognitive disorder itself, or the possibility of Alzheimer's disease in individuals with Down's syndrome. Identifying altered P300 latencies and amplitudes in subjects with Down's syndrome demonstrates the importance of this procedure, suggesting that surveys to monitor the progression of these cases could be undertaken to clarify the behavior of mentally retarded individuals without Down's syndrome, of individuals with Alzheimer's disease, of individuals with neuroendocrine disorders, and of healthy individuals.

CONCLUSION

In young adults with Down's syndrome N1, P2, N2 and P3 latencies were elevated and N2-P3 amplitudes were decreased in the event-related long-latency auditory evoked potential (P300), suggesting loss of integration in the auditory association area with cortical and subcortical areas of the central nervous system.
  21 in total

1.  Evoked-potential correlates of stimulus uncertainty.

Authors:  S Sutton; M Braren; J Zubin; E R John
Journal:  Science       Date:  1965-11-26       Impact factor: 47.728

2.  Effects of aging on event-related brain potentials and reaction times in an auditory oddball task.

Authors:  V J Iragui; M Kutas; M R Mitchiner; S A Hillyard
Journal:  Psychophysiology       Date:  1993-01       Impact factor: 4.016

3.  Clinical application of the P3 component of event-related potentials. I. Normal aging.

Authors:  A Pfefferbaum; J M Ford; B G Wenegrat; W T Roth; B S Kopell
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-04

4.  Down syndrome individuals fail to habituate cortical evoked potentials.

Authors:  E W Schafer; H V Peeke
Journal:  Am J Ment Defic       Date:  1982-11

5.  Longevity and mortality in Down's syndrome.

Authors:  M E Thase
Journal:  J Ment Defic Res       Date:  1982-09

Review 6.  Electrophysiology of cognitive processing.

Authors:  S A Hillyard; M Kutas
Journal:  Annu Rev Psychol       Date:  1983       Impact factor: 24.137

7.  The P300 component of the event-related brain potential as an index of information processing.

Authors:  C C Duncan-Johnson; E Donchin
Journal:  Biol Psychol       Date:  1982 Feb-Mar       Impact factor: 3.251

8.  The visually evoked potential in twins.

Authors:  R E Dustman; E C Beck
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1965-12

9.  P300 abnormality in schizophrenic subtypes.

Authors:  D St Clair; D Blackwood; W Muir
Journal:  J Psychiatr Res       Date:  1989       Impact factor: 4.791

Review 10.  The event-related P300 potential analysis of cognitive human brain aging: a review.

Authors:  C F Kügler; A Taghavy; D Platt
Journal:  Gerontology       Date:  1993       Impact factor: 5.140

View more
  4 in total

1.  Event-related potential alterations in fragile X syndrome.

Authors:  Inga S Knoth; Sarah Lippé
Journal:  Front Hum Neurosci       Date:  2012-09-24       Impact factor: 3.169

2.  Electrophysiological assessment of auditory processing disorder in children with non-syndromic cleft lip and/or palate.

Authors:  Xiaoran Ma; Bradley McPherson; Lian Ma
Journal:  PeerJ       Date:  2016-08-25       Impact factor: 2.984

3.  Hearing impairment in murine model of Down syndrome.

Authors:  Guang-Di Chen; Li Li; Andrew McCall; Dalian Ding; Zhuo Xing; Y Eugene Yu; Richard Salvi
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

Review 4.  Applicability of the P300 frequency pattern test to assess auditory processing.

Authors:  Elisângela Barros Soares Mendonça; Lilian Ferreira Muniz; Mariana de Carvalho Leal; Alcides da Silva Diniz
Journal:  Braz J Otorhinolaryngol       Date:  2013-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.